Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Galera Therapeutics Inc (NQ: GRTX )

0.1450 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Galera Therapeutics Inc

< Previous 1 2 3 4 5 6 7 Next >
Galera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis
From Galera Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
NDA based on two positive randomized, double-blinded, placebo-controlled trials which enrolled a total of 678 patients 
From Galera Therapeutics
Via GlobeNewswire
Recap: Galera Therapeutics Q2 Earnings
  Galera Therapeutics (NASDAQ:GRTX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Galera Therapeutics' Rucosopasem Shows Early Anti-Cancer Activity, Pulmonary Function Preservation
Via Benzinga
Galera to Present at Piper Sandler Annual Healthcare Conference
From Galera Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
From Galera Therapeutics
Via GlobeNewswire
Galera Therapeutics' Avasopasem Reduces Chemo-Related Kidney Disease By 50% Versus Placebo At One-Year
Via Benzinga
Galera Therapeutics: Q1 Earnings Insights
Galera Therapeutics (NASDAQ:GRTX) reported its Q1 earnings results on Monday, May 16, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Galera Posts Topline Data From Avasopasem Study In Chemoradiotherapy-Induced Esophagitis
Via Benzinga
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
From Galera Therapeutics
Via GlobeNewswire
Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
  
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 137 stocks made new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering. 
Via Benzinga
110 Biggest Movers From Friday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 9.6% to $23.84 during Wednesday's after-market session. The market value of their outstanding shares is at $312.8 million. As per the... 
Via Benzinga
Galera Therapeutics: Q4 Earnings Insights
Galera Therapeutics (NASDAQ:GRTX) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Avidity Biosciences (NASDAQ:RNA) s... 
Via Benzinga
65 Biggest Movers From Yesterday
Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Genprex (NASDAQ:GNPX) stock moved upwards by 117.5% to $2.85 during Monday's regular session. Genprex's stock is trading at a volume of 101.5 million... 
Via Benzinga
How Is The Market Feeling About Galera Therapeutics Inc?
Galera Therapeutics Inc's (NASDAQ:GRTX) short percent of float has risen 14.61% since last its last report. The company recently reported that it has 739.10 thousand shares... 
Via Benzinga
Looking Into Galera Therapeutics Inc's Recent Short Interest
Galera Therapeutics Inc's (NASDAQ:GRTX) short percent of float has risen 14.61% since last its last report. The company recently reported that it has 739.10 thousand shares sold... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.